Advances In Patient Tumoroid Screening
Michael Churchill,
Lead Scientist,
SEngine Precision Medicine
Ex-vivo organoid testing provides a 100-arm clinical trial for colorectal cancer patients. The results of this trial have been used to improve patient outcomes beyond that offered by the current standard of care.
|
|
